Anticalins directed against the fibronectin extra domain B as diagnostic tracers for glioblastomas-Reference-Cited by-同舟云学术

Anticalins directed against the fibronectin extra domain B as diagnostic tracers for glioblastomas

Published:2015-10-15 Issue:5 Volume:138 Page:1269-1280
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Albrecht Valerie¹,Richter Antonia²,Pfeiffer Sarah³,Gebauer Michaela²,Lindner Simon³,Gieser Eugenie¹,Schüller Ulrich⁴,Schichor Christian¹,Gildehaus Franz Josef³,Bartenstein Peter³,Tonn Jörg-Christian¹,Skerra Arne²,Glass Rainer¹

Affiliation:

1. Department of Neurosurgery; Neurosurgical Research, University of Munich; Munich Germany

2. Munich Center for Integrated Protein Science (CIPS-M) & Lehrstuhl für Biologische Chemie, Technische Universität München; Freising-Weihenstephan Germany

3. Department of Nuclear Medicine; University of Munich; Munich Germany

4. Center for Neuropathology and Prion Research, University of Munich; Munich Germany

Funder

Deutsche Forschungsgemeinschaft (DFG) in frame of the Collaborative Research Centre

Anni-Hofmann Stiftung (for RG)

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ijc.29874/fullpdf

Reference36 articles.

1. The 2007 WHO classification of tumours of the central nervous system;Louis;Acta Neuropathol,2007

2. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009;Dolecek;Neuro-Oncology,2012

3. Epidemiology of glial and non-glial brain tumours in Europe;Crocetti;Eur J Cancer,2012

4. Gross total but not incomplete resection of glioblastoma prolongs survival in the era of radiochemotherapy;Kreth;Ann Oncol,2013

5. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticalin N- or C-Terminal on a Monoclonal Antibody Affects Both Production and In Vitro Functionality;Antibodies;2022-08-22

2. Emerging new therapeutic antibody derivatives for cancer treatment;Signal Transduction and Targeted Therapy;2022-02-07

3. Protein scaffolds: antibody alternatives for cancer diagnosis and therapy;RSC Chemical Biology;2022

4. Extra-domain B of fibronectin as an alternative target for drug delivery and a cancer diagnostic and prognostic biomarker for malignant glioma;Theranostics;2021

5. Anticalin® proteins: from bench to bedside;Expert Opinion on Biological Therapy;2020-11-01